Related Experiment Video
Updated: May 11, 2026
14:34
A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Pharmaceutical pictograms: a model for development and testing for comprehension and utility.
1Massachusetts College of Pharmacy & Health Sciences, 179 Longwood Ave., Boston, MA 02115, USA.
Research in Social & Administrative Pharmacy : RSAP
|May 18, 2013
Summary
Pictograms improve medication understanding and adherence, but comprehension varies. Patient counseling on pictogram use significantly enhances their effectiveness for better drug information recall and use.
Area of Science:
- Health literacy
- Pharmaceutical sciences
- Human-computer interaction
Background:
- Growing concerns regarding patients' medication literacy skills necessitate improved information materials.
- Effective drug use and patient understanding are paramount in healthcare.
Purpose of the Study:
- To review existing pictogram development projects.
- To propose a model for pharmaceutical pictogram development and testing.
- To enhance comprehension and use of medication information.
Main Methods:
- Summarizing previous pictogram development efforts in healthcare, pharmacy, engineering, and safety.
- Assessing pictogram impact on knowledge acquisition, information retention, and adherence.
- Analyzing comprehension and recall levels of various pictogram types.
Main Results:
- Pictograms are crucial for enhancing medication information comprehension, recall, and adherence.
- Many pictograms exhibit low comprehension levels, with inconsistent impacts on medication knowledge.
- Patient counseling on pictogram meaning and use significantly boosts their effectiveness.
Conclusions:
- Pictograms are vital for redesigning medication information to improve patient outcomes.
- A structured model for pictogram development and testing is essential for effective pharmaceutical communication.
- Further research is needed to optimize pictogram design and integration into patient education.
Related Concept Videos
01:27Pharmacodynamic Models: Overview
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
01:20Pharmacokinetic Models: Overview
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Model Components
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:23Dosage Regimen Designs: Nomograms and Tabulations
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...